Upgrade to SI Premium - Free Trial

Novo Nordisk (NVO) sales jump on strong demand for obesity drug

May 2, 2024 6:23 AM
Novo Nordisk (NYSE: NVO) reported a robust first quarter with a 24% increase in sales at constant exchange rates (CER) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst EPS View Earnings Guidance Hot List

Next Articles